How Localized Z-Disc Damage Affects Force Generation and Gene Expression in Cardiomyocytes
Dominik Müller1,2,3, Sören Donath1,3, Emanuel Georg Brückner1,3
1Institute of Quantum Optics, Leibniz University Hannover, 30167 Hannover, Germany.
Bioengineering (Basel, Switzerland)
|December 23, 2021
Summary
Z-disc damage in human pluripotent stem cell-derived cardiomyocytes significantly weakens force generation. This study reveals key gene expression changes, offering insights into sarcomeric disorders and potential therapies.
Area of Science:
- Cardiovascular Biology
- Cellular Mechanics
- Stem Cell Research
Background:
- The Z-disc is crucial for cardiomyocyte (CM) function and sarcomeric cytoskeletal organization.
- Understanding Z-disc related cardiomyopathies requires novel models of Z-disc damage.
- Human pluripotent stem cell (hPSC)-derived CMs offer an in vitro model for studying the sarcomeric cytoskeleton.
Purpose of the Study:
- To develop and utilize a novel model for Z-disc damage in hPSC-derived CMs.
- To investigate the functional and transcriptional consequences of Z-disc manipulation.
- To gain insights into Z-disc related cardiomyopathies and potential therapeutic strategies.
Main Methods:
- Utilized a femtosecond laser system for precise Z-disc ablation in hPSC-derived CMs.
- Assessed changes in force generation using traction force microscopy.
- Analyzed gene expression profiles to identify transcriptional responses to Z-disc damage.
Main Results:
- Significant reduction in force generation observed after Z-disc removal.
- No significant alteration in contraction frequency detected post-manipulation.
- Upregulation of stress-related gene NF-kB, ACTN2, and FLNc observed.
- Downregulation of cardiac troponin I (TNNI3) and cardiac muscle troponin T (TNNT2) noted.
Conclusions:
- Z-disc damage in hPSC-derived CMs leads to impaired force generation and specific gene expression changes.
- Findings elucidate the transcriptional coupling between Z-disc damage and functional deficits.
- This research provides a foundation for developing novel therapies for sarcomeric disorders.


